Following Presidential Office Recognition, OBI Pharma Showcases the Strength of Its Obrion® ADC Platform and Accelerates Global Licensing to Capture Expanding Market Opportunities

OBI Pharma, Inc. announced today that Acting CEO Dr. Ya-Chi Chen recently represented the Company at the Presidential Office, where she joined fellow recipients of the 2026 Taiwan BIO Awards in a meeting with President William Lai.